Cart
sales@molnova.com
Syk-IN-3
CAS No. 1312534-69-2
Syk-IN-3( —— )
Catalog No. M33132 CAS No. 1312534-69-2
Syk-IN-3 is a Syk inhibitor with potential anti-inflammatory and anticancer activity and can be used to study immune dysregulation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 603 | Get Quote |
|
| 5MG | 922 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSyk-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionSyk-IN-3 is a Syk inhibitor with potential anti-inflammatory and anticancer activity and can be used to study immune dysregulation.
-
DescriptionSyk-IN-3, a potent spleen tyrosine kinase (Syk) inhibitor, extracted from patent WO2011075515A1, compound example 152, has an IC50 of 1 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetSyk
-
RecptorSyk
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1312534-69-2
-
Formula Weight452.57
-
Molecular FormulaC24H28N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@]1(CC(C)(C)[C@@H](C(O)=O)CC1)C=2SC(=CN2)C3=CC(NC=4N=C(C)C=CN4)=CC(C)=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Muller S, et al. Donated chemical probes for open science.CITE?THIS ARTICLEAS:?eLife 2018;7:e34311.
molnova catalog
related products
-
Sovleplenib
Sovleplenib (HMPL523) is an orally available, selective and potent inhibitor of the splenic tyrosine kinase SYK with an IC50 of 25 nM.Sovleplenib has antitumor activity and may be used in studies of immune thrombocytopenia (ITP).
-
Fostamatinib
Fostamatinib (R788 disodium salt) is a prodrug of the active metabolite R406, which is a potent, ATP-competitive inhibitor of Syk kinase with Ki/IC50 of 30/41 nM.
-
Mitapivat
Mitapivat, also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.
